Skip to main content
Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: Results from a phase 3 randomized, double-blind, placebo-controlled trial
Published Web Location
http://europepmc.org/articles/PMC5033065?pdf=renderNo data is associated with this publication.
Abstract
© 2015 European Society of Cardiology. Aims: Hyperkalaemia in heart failure patients limits use of cardioprotective renin-angiotensin-aldosterone system inhibitors (RAASi). Sodium zirconium cyclosilicate (ZS-9) is a selective potassium ion trap, whose mech
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.